StockNews.AI
IART
StockNews.AI
5 hrs

Integra LifeSciences to Spotlight Neurosurgical Product Portfolio at the Congress of Neurological Surgeons (CNS) Annual Meeting

1. Integra LifeSciences will exhibit at the CNS Annual Meeting. 2. New products featured include Durepair Dura Matrix and Mayfield Ghost. 3. The event enhances connections with the neurosurgical community. 4. Integra aims to advance neurosurgical care through innovation.

4m saved
Insight
Article

FAQ

Why Bullish?

Integrating new products into IART's portfolio can boost sales and investor confidence, similar to past product launches which have shown positive impacts on share price.

How important is it?

The article highlights a significant event showcasing innovative products, likely to attract investor interest.

Why Short Term?

The upcoming CNS Annual Meeting will provide immediate visibility and potential sales opportunities in the short-term, similar to past conference impacts.

Related Companies

CERNSYK
PRINCETON, N.J., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, is pleased to announce its exhibition at the CNS Annual Meeting, from October 11 through 15, 2025, in Los Angeles, California. The company’s booth will spotlight its industry-leading products, while featuring two recent additions to the portfolio - Durepair Dura Regeneration Matrix and Mayfield Ghost Base Unit, Post. Durepair Dura Regeneration Matrix is a strong suturable graft1 that complements Integra’s extensive portfolio of dural grafts and sealants, and the Mayfield Ghost device is engineered with minimal artifact materials to support clear visualization of anatomical structure for surgical procedures. "CNS is an excellent opportunity for our team to connect with the neurosurgical community—experts who are just as passionate as we are about restoring patient lives,” said Mike McBreen, executive vice president and president, Codman Specialty Surgical. “The conference is also a great platform to showcase our latest innovations and demonstrate our dedication to advancing neurosurgical care through medical technologies.” At CNS, Integra will be located at booth #713. Attendees can learn more about several of the company’s medical technologies, including the CereLink® ICP Monitoring System, CUSA® Clarity Tissue Ablation System, Aurora® Surgiscope System, and the Certas® Plus Programmable Valve. About Integra LifeSciencesAt Integra LifeSciences, we are driven by our purpose of restoring patients’ lives. We innovate treatment pathways to advance patient outcomes and set new standards of surgical, neurologic, and regenerative care. We offer a comprehensive portfolio of high quality, leadership medical technology brands. For the latest news and information about Integra and its products, please visit www.integralife.com. 1 Zerris et al. J of Biomed Mat Rsch 2007; 83B (2):580-588 (Canine Study) Investor Relations:Chris Ward(609) 772-7736chris.ward@integralife.com Media Contact:Laurene Isip(609) 208-8121laurene.isip@integralife.com

Related News